INAB In8bio Inc

USD 0.29 0.00 ( 0.00%)
Icon

In8bio Inc (INAB) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.29

0.00 (0.00%)

USD 0.02B

8.23M

USD 1.60(+449.83%)

N/A

Icon

INAB

In8bio Inc (USD)
COMMON STOCK | NSD
USD 0.29
0.00 ( 0.00%)
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.02B

N/A

USD 0.29

In8bio Inc (INAB) Stock Forecast

Show ratings and price targets of :
USD 1.60
(+449.83%)

Based on the In8bio Inc stock forecast from 2 analysts, the average analyst target price for In8bio Inc is USD 1.60 over the next 12 months. In8bio Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of In8bio Inc is Bearish, which is based on 1 positive signals and 6 negative signals. At the last closing, In8bio Inc’s stock price was USD 0.29. In8bio Inc’s stock price has changed by +11.92% over the past week, -3.96% over the past month and -73.78% over the last year.

No recent analyst target price found for In8bio Inc
No recent average analyst rating found for In8bio Inc

Company Overview In8bio Inc

IN8bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of gamma-delta T cell therapies for the treatment of solid and liquid tumors. Its lead product candidates include INB-400, which is in Phase 2 clinical trial to ...Read More

https://in8bio.com

350 5th Avenue, New York, NY, United States, 10118

39

December

USD

USA

Adjusted Closing Price for In8bio Inc (INAB)

Loading...

Unadjusted Closing Price for In8bio Inc (INAB)

Loading...

Share Trading Volume for In8bio Inc Shares

Loading...

Compare Performance of In8bio Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for INAB

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To In8bio Inc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VRTX
Vertex Pharmaceuticals Inc 0.00 (0.00%) USD118.90B 32.57 220.35

Frequently Asked Questions About In8bio Inc (INAB) Stock

Based on ratings from 2 analysts In8bio Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 2 buy, sell and hold ratings.

Unfortunately we do not have enough data on INAB's stock to indicate if its a good dividend stock.

Based on targets from 2 analysts, the average taret price for INAB is USD 1.60 over the next 12 months. The maximum analyst target price is USD 2 while the minimum anlayst target price is USD 1.2.

Unfortunately we do not have enough data on INAB's stock to indicate if its overvalued.

The last closing price of INAB's stock was USD 0.29.

The most recent market capitalization for INAB is USD 0.02B.

Based on targets from 2 analysts, the average taret price for INAB is projected at USD 1.60 over the next 12 months. This means that INAB's stock price may go up by +449.83% over the next 12 months.

We can't find any ETFs which contains In8bio Inc's stock.

As per our most recent records In8bio Inc has 39 Employees.

In8bio Inc's registered address is 350 5th Avenue, New York, NY, United States, 10118. You can get more information about it from In8bio Inc's website at https://in8bio.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Frequently Asked Questions About In8bio Inc (INAB) Stock

Based on ratings from 2 analysts In8bio Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 2 buy, sell and hold ratings.

Unfortunately we do not have enough data on INAB's stock to indicate if its a good dividend stock.

Based on targets from 2 analysts, the average taret price for INAB is USD 1.60 over the next 12 months. The maximum analyst target price is USD 2 while the minimum anlayst target price is USD 1.2.

Unfortunately we do not have enough data on INAB's stock to indicate if its overvalued.

The last closing price of INAB's stock was USD 0.29.

The most recent market capitalization for INAB is USD 0.02B.

Based on targets from 2 analysts, the average taret price for INAB is projected at USD 1.60 over the next 12 months. This means that INAB's stock price may go up by +449.83% over the next 12 months.

We can't find any ETFs which contains In8bio Inc's stock.

As per our most recent records In8bio Inc has 39 Employees.

In8bio Inc's registered address is 350 5th Avenue, New York, NY, United States, 10118. You can get more information about it from In8bio Inc's website at https://in8bio.com.
Loading...